Montana Gov. Greg Gianforte’s administration is reviving efforts to do away with a panel that hears appeals from people who were denied public assistance to afford basics such as food and health care. The effort, billed as a way to reduce red tape in government, would leave district court as the only option outside of…
Highly preventable if diagnosed and managed early, CAD should be a healthcare priority. Both patients and providers have pivotal roles in driving this change. The post The Case for Prioritizing the Number One Killer: Cardiovascular Disease appeared first on MedCity News.
As healthcare organizations experiment with AI, they’re learning more about the technology as they generate evidence that these tools improve efficiency and reduce costs. The post To Be or Not to Be: Addressing the Challenge of AI-Generated Hallucinations in Healthcare appeared first on MedCity News.
Four years before Kimberly Gallagher enrolled in Medicaid herself, the public health insurance program’s rules prompted her to make an excruciating choice — to give up guardianship of her son so she could work as his caregiver. Now, another proposed twist in the rules could mean that, even though Missouri pays her to do that…
This edition highlights vaccine hesitancy and misinformation around MMR (measles, mumps, and rubella) vaccines as children return to school and measles cases resurge in parts of the U.S. It also examines emerging narratives around COVID-19 vaccine misinformation following the FDA approval of COVID-19 boosters and false claims linking mpox to the vaccines.
SALINAS, Calif. — This coastal valley made famous by the novelist John Steinbeck is sometimes known affectionately as “America’s salad bowl,” though the planting and harvesting is done mostly by immigrants from Mexico. For Taylor Farms, a major global purveyor of packaged salads and cut vegetables, that’s made it a logical place to pioneer a…
Payers will often look to disease analogs when making pricing and coverage decisions. These disease analogs can inform the level of rebates, need for prior authorization/utilization management, and the drug’s cost sharing tier. Traditionally, however, disease analogs are selected on an ad hoc basis. In a recent JMCP paper titled “A structured approach for identifying…
The current wave of generative AI has captured public imagination, but we must temper our expectations. While these models demonstrate impressive capabilities in processing vast amounts of medical literature and generating coherent text, they’re far from perfect. The post Fluency Isn’t Intelligence in Healthcare appeared first on MedCity News.
The promise of automation in RCM is undeniable, but achieving it requires more than simply adopting new tools. Hospitals must take deliberate steps to prepare their people, processes, and systems for change. The post 5 Tips for How Hospitals Should Prepare for RCM Automation appeared first on MedCity News.
Precigen’s Papzimeos is the first FDA-approved drug for the rare disease recurrent respiratory papillomatosis, or RRP. While this immunotherapy carries blockbuster expectations, Precigen’s financial reports indicate budgetary challenges. The post First Therapy for Rare Tumor Is a Blockbuster Prospect, But Does Precigen Have the Cash to Make It Happen? appeared first on MedCity News.